Company: ARTL
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0001640334-25-000335
Chunk: 106

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1
Chunk 106
---
5,169   4,531 Research and development tax credits (b)  (1,349)  (1,206)Other research and development (c)  690   1,078       Total research and development $5,993  $5,696   (a)Consists of sales and marketing, investor relations, travel and other office expenses.  (b)Reflects tax credits from United Kingdom government recorded directly as a reduction of research and development expense upon receipt.  (c)Consists of supplies and other items used in research and development activities.  

NOTE 4 – RELATED PARTY TRANSACTIONS During the years ended December 31, 2024, and 2023, a company owned by the Senior Vice President, European Operations, provided consulting services totaling $9 and $12, respectively. As of December 31, 2024, and 2023, there was $1 and $2, outstanding, respectively. During the years ended December 31, 2024, and 2023, a company significantly influenced by a director of a subsidiary of the Company provided professional services totaling $100 and $135, respectively. As of December 31, 2024, and 2023, there was $36 and $5 outstanding, respectively. During the years ended December 31, 2024, and 2023, a company controlled by a director of a subsidiary of the Company provided professional services totaling $78 and $77, respectively. As of December 31, 2024, and 2023, there was $24 and $23 outstanding, respectively. 

 F-11Table of Contents

NOTE 5 - EQUITY

 Preferred shares The Company has authorized 416,667 shares of preferred stock with a par value of $0.001 per share. As of December 31, 2024, and 2023, there were no shares of preferred stock issued or outstanding. Common Shares The Company has authorized 50,000,000 shares of Common Stock with a par value of $0.001 per share. Each share of Common Stock entitles the holder to one vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought. During the years ended December 31, 2024, and